In summary, our findings demonstrate DT-13 can effectively induce apoptosis and inhibit metastasis in prostate cancer cells, the mechanism of which might be attributed to the blockade of PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and prostate cancer.